跳至主要内容
临床试验/NCT05741957
NCT05741957进行中(未招募)不适用

Examining the Optimal Exercise Frequency for Alleviating Liver Fat in Centrally Obese Adults With Non-Alcoholic Fatty Liver Disease (NAFLD): A Comparative Randomized Controlled Trial

The University of Hong Kong2 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2023年3月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
300
试验地点
2
主要终点
Change in Liver Fat

研究概览

简要总结

This study aims to examine the comparative effectiveness of different exercise frequencies (once-a-week vs. thrice-a-week) for reducing liver fat in centrally obese adults with non-alcoholic fatty liver disease (NAFLD), with weekly exercise volumes aligned with the World Health Organization's physical activity recommendations.

详细描述

This study is a three-arm randomized controlled trial. Participants will be randomly allocated to the once-a-week exercise group, thrice-a-week exercise group, or usual care control group. The exercise intervention groups will receive once-a-week or thrice-a-week exercise (with matched weekly exercise volumes). The usual care control group will receive general health education. All interventions will last for 4 months. Outcome measures will be examined at baseline, 4 months (post-intervention), and 10 months (6-month follow-up).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 69 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Cantonese, Mandarin, or English speaking Chinese;
  • Aged 18-69;
  • Male or female;
  • Centrally obese according to the Asian-specific cut-off (waist circumference ≥90 cm for males; ≥80 cm for females) and with BMI ≥23;
  • With NAFLD (defined as >5% intrahepatic triglycerides assessed by 1H-MRS);
  • Willing to participate in exercise training to improve NAFLD.

排除标准

  • Regular exercise training (>3 sessions of >60 min of moderate-intensity exercise training weekly) in the past 6 months;
  • Medical history of cardiovascular disease, chronic pulmonary or kidney disease, heart failure, cancer, and/or liver disease except NAFLD;
  • Somatic conditions that limit exercise participation (e.g., limb loss);
  • Impaired mobility due to chronic disease (e.g., chronic arthritis/osteoarthritis, neurological, musculoskeletal, and autoimmune diseases);
  • Daily smoking habit;
  • Excess alcohol consumption (daily ≥20 g of alcohol for men and ≥10 g for women) in the past 1 year;
  • Consumption of certain drugs (e.g., tamoxifen and estrogen) known to be secondary causes of steatosis;
  • Surgery, therapy, or medication for obesity or weight loss in the past 6 months (e.g., gastric bypass, gastric band, sleeve gastrectomy, gastric reduction duodenal switch, or dietitian-prescribed dietary program);
  • Physical changes that considerably affect body composition and weight (e.g., anorexia nervosa, bulimia nervosa, prolonged gastrointestinal and digestive disorders) during the study period.

研究组 & 干预措施

Once-a-week Exercise

Experimental

Once-a-week vigorous-intensity exercise for 4 months.

干预措施: Once-a-week Exercise (Behavioral)

Thrice-a-week Exercise

Experimental

Thrice-a-week vigorous-intensity exercise for 4 months.

干预措施: Thrice-a-week Exercise (Behavioral)

Usual Care Control

Other

Bi-weekly health education for 4 months.

干预措施: Usual Care Control (Other)

结局指标

主要结局

Change in Liver Fat

时间窗: Baseline and 4 months (post-intervention)

Intrahepatic triglycerides will be assessed using proton magnetic resonance spectroscopy (1H-MRS) in a 3×3×3 cm voxel.

次要结局

  • Change in Abdominal Visceral Fat(Baseline, 4 months (post-intervention), and 10 months (follow-up))
  • Change in Body Mass Index(Baseline, 4 months (post-intervention), and 10 months (follow-up))
  • Change in Maximal Oxygen Consumption(Baseline, 4 months (post-intervention), and 10 months (follow-up))
  • Number of Adverse Events(Baseline, 4 months (post-intervention), and 10 months (follow-up))
  • Change in Liver Fat(Baseline and 10 months (follow-up))
  • Change in Body Fat(Baseline, 4 months (post-intervention), and 10 months (follow-up))
  • Change in Mental Component Summary Score of the 12-Item Short-Form Health Survey(Baseline, 4 months (post-intervention), and 10 months (follow-up))
  • Change in Waist Circumference(Baseline, 4 months (post-intervention), and 10 months (follow-up))
  • Change in Physical Component Summary Score of the 12-Item Short-Form Health Survey(Baseline, 4 months (post-intervention), and 10 months (follow-up))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Parco M. Siu, PhD

Associate Professor and Division Head

The University of Hong Kong

研究点 (2)

Loading locations...

相似试验